PT  - JOURNAL ARTICLE
AU  - Alexander, Lori
ED  - Viswanathan, Prabhakar
TI  - Novel Agent Found to Reduce HbA1C in Type 2 Diabetes
DP  - 2011 Sep 01
TA  - MD Conference Express
PG  - 13--14
VI  - 11
IP  - 8
4099  - http://mdc.sagepub.com/content/11/8/13.short
4100  - http://mdc.sagepub.com/content/11/8/13.full
AB  - A randomized, double-blind, multicenter study demonstrated that a G-protein-coupled receptor 40 (GPR40) agonist had glucose-lowering efficacy for the treatment of type 2 diabetes. The novel agent significantly reduced HbA1C compared with placebo, with efficacy that was comparable with glimepiride but with a significantly lower rate of hypoglycemia.